Josep M. Miró
Research groups
- AIDS and HIV infection Accredited researcher (R3A)
- Endocarditis. Cardiovascular infections. Experimental model Group leader (R4)
About me
Dr. José M. Miró is Senior Consultant of Infectious Diseases at the Hospital Clinic of Barcelona, Professor of Medicine at the University of Barcelona, and Director of the Master on AIDS of the University of Barcelona.
Dr. Miro is an accredited IDIBAPS researcher who has two research lines: 1) Infective endocarditis (including the experimental model), as Group leader (R4); and, HIV/AIDS (epidemiological studies in HIV cohorts, primary HIV-1 infection, tuberculosis and other opportunistic Infections, clinical trials in advanced patients and solid organ transplantation in HIV-1 infected patients), as R3A researcher.
Dr. Miro has published 800 articles in peer-review journals (h-index 72).
Featured publications
-
Immunological and virological findings in a patient with exceptional post-treatment control: a case report
Authors: Climent N, Ambrosioni J, González T, Xufré C, Casadellà M, Noguera-Julian M, Paredes R, Plana M, Grau-Expósito J, Mallolas J, Alcamí J, Sánchez-Palomino S, Miró JM, Hospital Clínic de Barcelona PHI investigators.Reference: Lancet Hiv 2023. -
Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high-income countries: an international collaborative cohort study
Authors: Ingle SM; Miro JM; May MT; Cain LE; Schwimmer C; Zangerle R; Sambatakou H; Cazanave C; Reiss P; Brandes V; Bucher HC; Sabin C; Vidal F; Obel N; Mocroft A; Wittkop L; D'arminio Monforte A; Torti C; Mussini C; Furrer H; Konopnicki D; Tiera R; Saag MS; Crane HM; Moore RD; Jacobson JM; Mathews WC; Geng E; Eron JJ; Althoff KN; Kroch A; Lang R; Gill MJ; Sterne JAC; ART-CC; COHERE in EuroCoord; CNICS and NA-ACCORD.Reference: Clinical Infectious Diseases 2023. -
The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria
Authors: Fowler VG; Durack DT; Selton-Suty C; Athan E; Bayer AS; Chamis AL; Dahl A; DiBernardo L; Durante-Mangoni E; Duval X; Fortes C; Fosbøl E; Hannan MM; Hasse B; Hoen B; Karchmer AW; Mestres CA; Petti CA; Pizzi MN; Preston SD; Roque A; Vandenesch F; van der Meer JTM; van der Vaart TW; Miro JM.Reference: Clinical Infectious Diseases 2023. -
Clinical characteristics and outcome of infective endocarditis due to Abiotrophia and Granulicatella compared to Viridans group streptococci
Authors: Téllez A, Ambrosioni J, Hernández-Meneses M, Llopis J, Ripa M, Chambers ST, Holland D, Almela M, Fernández-Hidalgo N, Almirante B, Bouza E, Strahilevitz J, Hannan MM, Harkness J, Kanafani ZA, Lalani T, Lang S, Raymond N, Read K, Vinogradova T, Woods CW, Wray D, Moreno A, Chu VH, Miro JM, International Collaboration on Endocarditis (ICE) Investigators.Reference: Journal Of Infection 2022. -
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
Authors: Nomah DK, Reyes-Urueña J, Díaz Y, Moreno S, Aceiton J, Bruguera A, Vivanco-Hidalgo RM, Llibre JM, Domingo P, Falcó V, Imaz A, Cortés C, Force L, Letang E, Vilaró I, Casabona J, Miro JM, PISCIS study group.Reference: Lancet Hiv 2021. -
Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs
Authors: Pericàs JM, Llopis J, Athan E, Hernández-Meneses M, Hannan MM, Murdoch DR, Kanafani Z, Freiberger T, Strahilevitz J, Fernández-Hidalgo N, Lamas C, Durante-Mangoni E, Tattevin P, Nacinovich F, Chu VH, Miró JM, International Collaboration on Endocarditis (ICE) Investigators.Reference: Journal Of The American College Of Cardiology 2021. -
Overview of SARS-CoV-2 infection in adults living with HIV
Authors: Ambrosioni J, Blanco JL, Reyes-Urueña JM, Davies MA, Sued O, Marcos MA, Martínez E, Bertagnolio S, Alcamí J, Miro JM, COVID-19 in HIV Investigators.Reference: Lancet Hiv 2021. -
Outpatient Parenteral Antibiotic Treatment (OPAT) for Infective Endocarditis: a Prospective Cohort Study From the GAMES Cohort
Authors: Pericà S JM, Llopis J, González-Ramallo V, Goenaga MÁ, Muñoz P, García-Leoni ME, Fariñas MC, Pajarón M, Ambrosioni J, Luque R, Goikoetxea J, Oteo JA, Carrizo E, Bodro M, Reguera-Iglesias JM, Navas E, Hidalgo-Tenorio C, Miró JM, Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES) investigators.Reference: Clinical Infectious Diseases 2019.
Featured Projects
-
In vitro and experimental endocarditis model study of the efficacy of new oral and parenteral combinations of antibiotics for outpatient treatment of infectious endocarditis
Principal investigator: Josep M. Miró MedaCode: PI20/00830Duration: 01/01/2021 - 31/12/2023 -
Prevention of vascular catheter-related infections by the FUNctionalization of CATHeters with thermically activated hydrogels with antimicrobial agents of broad spectrum (FUNCATH).
Principal investigator: Cristina Garcia de la MariaCode: 75/C/2018Duration: 15/01/2019 - 31/12/2022 -
Eficacia de nuevas pautas de tratamiento antibiótico de la endocarditis enterocócica evaluadas in vitro y en el modelo de endocarditis experimental.
Principal investigator: J.M. MiróCode: PI17/01251Duration: 01/01/2018 - 01/01/2020 -
Estudio clínico y experimental de la relación entre la CMI de vancomicina en Staphylococcus aureus sensible a meticilina (SASM) y el pronóstico de la endocarditis infecciosa (EI) izquierda causada SASM
Principal investigator: José María Miró MedaCode: 201526 10Duration: 01/01/2016 - 01/01/2018 -
A Multi-Center, Randomized, Open-Label, Comparative Study to Assess the Safety and Efficacy of a Treatment Algorithm to Reduce the Use of Vancomycin in Adult Patients with Intravenous Catheter associated Blood Stream Infections due to Staphylococci
Principal investigator: José María Miró Meda, Josep M. Miró MedaCode: BAA NIAID-DMID-NIH AI 200Duration: 01/01/2011 - 31/12/2017